Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system.

@article{Aneja2012HypofractionatedRT,
  title={Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system.},
  author={Sanjay Aneja and Ramya R Pratiwadi and James Byunghoon Yu},
  journal={Oncology},
  year={2012},
  volume={26 6},
  pages={512-8}
}
Prostate cancer is the second most common cause of cancer death in American men and represents a significant factor in US health care costs. Radiation therapy serves as one of the most effective treatments for prostate cancer. However, radiation is also an expensive treatment modality and is a significant contributor to the overall rise in the cost of prostate cancer care. Currently, standard external beam radiation therapy for prostate cancer consists of between 75.6 and 81.0 Gy of radiation… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2014
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Prostate cancer around the world. An overview.

Urologic oncology • 2010
View 4 Excerpts
Highly Influenced

of Health

US National Institute
Available from: http://www.clinicaltrials.gov. Accesssed March 12, • 2012
View 5 Excerpts
Highly Influenced

Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer.

Seminars in radiation oncology • 2008
View 3 Excerpts
Highly Influenced

Geographic analysis of the radiation oncology workforce.

International journal of radiation oncology, biology, physics • 2012
View 1 Excerpt

Similar Papers

Loading similar papers…